title: New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
authors.affiliation: SmithKline Beecham Pharmaceuticals Research & Development, Betchworth, United Kingdom.
authors.forename: I
authors.initials: I
authors.lastname: Chopra
authors.forename: J
authors.initials: J
authors.lastname: Hodgson
authors.forename: B
authors.initials: B
authors.lastname: Metcalf
authors.forename: G
authors.initials: G
authors.lastname: Poste
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D001428:Bacterial Vaccines; D003140:Communicable Disease Control / Q000639:trends*; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D004352:Drug Resistance, Microbial / Q000235:genetics / Q000502:physiology; D005798:Genes, Bacterial / Q000187:drug effects; D006801:Humans; D014774:Virulence / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines